Search

everythinglearnresearchcommunity

for

Search:↓

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Hair loss patients have different microbes in hair follicles, possibly affecting hair loss.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

The document details hair transplantation techniques and innovations, highlighting Follicular Unit Transplantation as the standard and discussing the effectiveness and challenges of the procedure.

Herbal products might promote hair growth with fewer side effects, but more research is needed to confirm their safety and effectiveness.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Consider benefits and risks of new alopecia treatments for safety.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Cyclodextrins improve finasteride's solubility and bioavailability for hair loss treatment.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

17α-Estradiol solution safely improves hair density and thickness in female pattern hair loss.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.